Bastide Le Confort Médical SA (EPA:BLC)
18.92
+0.44 (2.38%)
Oct 22, 2026, 5:35 PM CEST
EPA:BLC Financials Overview
Financials in millions EUR. Fiscal year is July - June.
Millions EUR. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Revenue Revenue Growth | 482.39 | 482.39 | 491.18 | 461.87 | 508.03 | 468.3 |
Revenue Growth | -5.50% | -1.79% | 6.35% | -9.09% | 8.48% | 5.46% |
Gross Profit Gross Profit Growth | 326.35 | 326.35 | 333 | 308.63 | 333.73 | 306.8 |
Operating Income Operating Income Growth | 47.83 | 47.83 | 45.19 | 38.52 | 42.82 | 38.93 |
Net Income Net Income Growth | 58.1 | 58.1 | 0.53 | -0.9 | 12.05 | 13.68 |
Earnings Per Share EPS Growth | - | - | 0.07 | -0.11 | 1.52 | 1.86 |
EPS Growth | - | - | - | - | -18.28% | 1.64% |
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Respiratory Support Respiratory Support Growth | 123.89 | 108.12 | 92.57 | 80.83 |
Nutrition Infusion Nutrition Infusion Growth | 85.79 | 81.45 | 73.94 | 58.96 |
Diabetes Diabetes Growth | 27.26 | 21.97 | 17.51 | 14.33 |
Stomatherapy-Urology-Healing Stomatherapy-Urology-Healing Growth | 26.15 | 25.33 | 38 | 45.63 |
Home Support Home Support Growth | 191.79 | 190.56 | 195.52 | 193.32 |
Unallocated Foreign Subsidiaries Unallocated Foreign Subsidiaries Growth | 36.3 | 34.39 | 90.43 | 75.24 |
Total Total Growth | 491.18 | 461.87 | 508.03 | 468.3 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Investments Cash & Investments Growth | 48.21 | 48.21 | 25.49 | 23.62 | 36.71 | 22.13 |
Total Debt Total Debt Growth | 299.13 | 299.13 | 411.16 | 408.65 | 427.39 | 419.23 |
Net Cash (Debt) Net Cash Growth | -250.92 | -250.92 | -385.67 | -385.03 | -390.69 | -397.1 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | - | - | -48.59 | -48.49 | -49.22 | -53.86 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 106.69 | 106.69 | 101.82 | 73.91 | 105.68 | 56.86 |
Capital Expenditures CapEx Growth | -51.02 | -51.02 | -60.08 | -49.45 | -53.63 | -53.27 |
Free Cash Flow Free Cash Flow Growth | 55.68 | 55.68 | 41.74 | 24.46 | 52.05 | 3.59 |
Free Cash Flow Growth | 0.40% | 33.38% | 70.68% | -53.01% | 1351.37% | -87.12% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Gross Margin | 67.65% | 67.65% | 67.80% | 66.82% | 65.69% | 65.51% |
Operating Margin | 9.92% | 9.92% | 9.20% | 8.34% | 8.43% | 8.31% |
Pretax Margin | 3.02% | 3.02% | 2.15% | 2.84% | 4.48% | 4.49% |
Profit Margin | 12.04% | 12.04% | 0.11% | -0.19% | 2.37% | 2.92% |
FCF Margin | 11.54% | 11.54% | 8.50% | 5.29% | 10.24% | 0.77% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 23, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 2.41 | 3.01 | 439.54 | - | 17.34 | 18.86 |
Forward PE | 11.13 | 13.76 | 10.15 | 6.01 | 8.91 | 12.44 |
P/FCF Ratio | 2.52 | 3.14 | 5.56 | 5.48 | 4.01 | 71.95 |
PS Ratio | 0.29 | 0.36 | 0.47 | 0.29 | 0.41 | 0.55 |